Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Retinal Vein Occlusion (CRVO)”

58 trials

Showing 20 of 58 results

Large-scale testing (Phase 3)Ended earlyNCT00500045
What this trial is testing

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

Who this might be right for
Central Retinal Vein OcclusionBranch Retinal Vein Occlusion
Palo Alto Medical Foundation 36
Not applicableStudy completedNCT01231633
What this trial is testing

Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Long Island Vitreoretinal Consultants 27
Large-scale testing (Phase 3)Study completedNCT00943072
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Macular Edema Secondary to Central Retinal Vein Occlusion
Regeneron Pharmaceuticals 189
Early research (Phase 1)Study completedNCT00403039
What this trial is testing

Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

Who this might be right for
Retinal Vein Occlusion
Vitreous -Retina- Macula Consultants of New York 41
Post-approval studies (Phase 4)Study completedNCT02274259
What this trial is testing

Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen

Who this might be right for
Central Retinal Vein Occlusion
Anders Kvanta 40
Not applicableStudy completedNCT02040220
What this trial is testing

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Bayer 385
Early research (Phase 1)Study completedNCT00406471
What this trial is testing

Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion

Who this might be right for
Ischemic Central Retinal Vein Occlusion
Greater Houston Retina Research 20
Testing effectiveness (Phase 2)UnknownNCT00370630
What this trial is testing

Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)

Who this might be right for
Retinovascular Disease
Shahid Beheshti University of Medical Sciences 15
Not applicableStudy completedNCT06495203
What this trial is testing

Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal Vein Occlusion
Bayer 1,350
Not applicableUnknownNCT01968616
What this trial is testing

Ranibizumab Treatment for Retinal Vein Occlusion

Who this might be right for
Macular Edema Due to BRVO/CRVO
Kyoto University, Graduate School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT01468844
What this trial is testing

Minocycline to Treat Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
National Eye Institute (NEI) 6
Post-approval studies (Phase 4)Ended earlyNCT00566761
What this trial is testing

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Asociación para Evitar la Ceguera en México 10
Early research (Phase 1)Study completedNCT02747030
What this trial is testing

Phase I RVC With Ocriplasmin for CRVO

Who this might be right for
Central Retinal Vein Occlusion
Universitaire Ziekenhuizen KU Leuven 4
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Post-approval studies (Phase 4)Study completedNCT02800642
What this trial is testing

Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

Who this might be right for
Central Retinal Vein Occlusion
Bayer 162
Testing effectiveness (Phase 2)UnknownNCT01178697
What this trial is testing

Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Shahid Beheshti University of Medical Sciences
Not applicableStudy completedNCT04793100
What this trial is testing

Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections

Who this might be right for
Central Retinal Vein Occlusion
Fondation Ophtalmologique Adolphe de Rothschild 60
Large-scale testing (Phase 3)Study completedNCT00906685
What this trial is testing

Bevacizumab for Central Retinal Vein Occlusion Study

Who this might be right for
Central Retinal Vein Occlusion
Anders Kvanta 60
Post-approval studies (Phase 4)UnknownNCT05282420
What this trial is testing

Ranibizumab Versus Aflibercept for CRVO in Young Patients.

Who this might be right for
Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
South Valley University 40
Not applicableUnknownNCT01303276
What this trial is testing

Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
University of Toronto 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation